Searched for
THYROCARE CEO
'Marriage will not work...': Thyrocare's Rs 5,000 crore man Dr A Velumani, reveals the common problem behind stagnant Rs 100 crore firms, according to himThyrocare founder Dr. A. Velumani observed that many profitable Indian companies with revenues over Rs 40 crore are stagnating due to exces...- Peak XV rejigs Surge; Digital lenders power through slowdownHappy Monday! Peak XV Partners is rebooting Surge after executive exits and a broader strategy reset. This and more in today’s ETtech Morni...
- Thyrocare names diagnostics sector veteran Ramesh Kinha as COOKinha will be responsible for overseeing lab operations and strengthening quality standards across the company’s network. He has earlier se...
- Thyrocare Technologies shares soar 16% to fresh 52-week high after Q2 PAT grows 82% YoYThyrocare Technologies shares touched a fresh 52-week high on Wednesday after a stellar 82% YoY growth in Q2FY26 PAT. The company's Revenue...
- Pharmeasy founder Siddharth Shah steps down as CEOPharmeasy founder Siddharth Shah has stepped down as the chief executive to assume the role of vice chairman of the company's board. Rahul ...
- Trolled for Ola ride, Rs 5,000 crore Thyrocare founder shares how he went to office in last 30 yearsThyrocare CEO Dr. A. Velumani shocked many by choosing a cab over luxury transportation, promoting frugality. He shared his journey of over...
- Thyrocare founder Velumani's choice of car ride shocks guests at 5-star hotelThyrocare CEO Dr. A Velumani surprised attendees at a high-profile event by opting for an OLA ride instead of a luxury car, despite the pre...
- Thyrocare to buy home ECG service provider Think HealthDiagnostic provider Thyrocare, backed by Pharmeasy, will acquire a 100% stake in Chennai's Think Health Diagnostics to venture into providi...
- Thyrocare seeing an easing off in price competition: MD“I believe this quarter is the sickness season. As we come into Jan-Feb-March, we move into the wellness side. But I am definitely seeing a...
- Thyrocare CEO speaks on margin contraction; says not in talks to sell stake at present“I have been guiding in all our investor calls that margin will be in that 30% ballpark. As I said in the last quarter, given that we have ...
- Thyrocare to stay focused on volumes, on time performance & qualityThe company is investing heavily on improving turnaround time and addressing quality perception of the brand in the market through a combin...
- Rahul Guha to join Thyrocare Technologies as MD & CEOA graduate of IIM Bangalore, Rahul Guha joins API Group to head its Diagnostics Business. Hehas spent almost 17 years at Boston Consulting ...
- Why PharmEasy bought ThyrocareIn today’s ETtech Morning Dispatch: The rationale for the Pharmacy-Thyrocare deal, according to their promoters; Mobile Premier League (MPL...
- PharmEasy to acquire 66% stake in Thyrocare for over Rs 4,500 crorePharmEasy is acquiring a majority stake in diagnostics chain Thyrocare Technologies, in what the online pharmacy claimed was the first ever...
- PharmEasy to acquire 66% stake in Thyrocare Tech, to make open offer to grab additional 26%PharmEasy claims to be India’s number one online pharmacy and diagnostics brand. Thyrocare prides itself as the largest diagnostic company.
- Diagnostic cos fall on Reliance Life’s proposed entryOn Monday, these three stocks fell between 1 per cent and 3 per cent.
- Leaders of Tomorrow kick-starts with Whitney Johnson & Brand CapitalEntrepreneurship is gathering momentum in India. Ambitious entrepreneurs are bringing in innovations and disrupting the Indian market. Lead...
- ABCI awards Mahashay Dharampal of MDH as Indian of the YearThe event saw Piyush Pandey, co-executive chairman and National Creative Director of Ogilvy & Mather India and Vice-Chairman of O&M Asia-Pa...
- GoQii launches new fitness band; preventive health servicesThe company is putting in place a marketplace model where it will bring on doctors who can advise users on their specific health queries, a...
- Thyrocare plans stake sale; SRL, Quest in raceThyrocare plans to carry out complex experiments such as in vitro tests and to also launch company-owned outlets.
Load More
